Citation Impact
Citing Papers
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens
2010
Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques
2019 StandoutNobel
Reading the glyco-code: New approaches to studying protein–carbohydrate interactions
2022 StandoutNobel
Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies
2016
Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape
2012
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
2010 Standout
The high mannose-type glycan binding lectin actinohivin: dimerization greatly improves anti-HIV activity
2011 StandoutNobel
Modulation of Glycan Recognition by Clustered Saccharide Patches
2014
Rational antibody-based HIV-1 vaccine design: current approaches and future directions
2010
Glycans in HIV-1 vaccine design – engaging the shield
2022
A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals
2010
Human milk oligosaccharides: Every baby needs a sugar mama
2012 Standout
22q11.21 Deletion Syndromes: A Review of Proximal, Central, and Distal Deletions and Their Associated Features
2015 Standout
Glandular trichomes: what comes after expressed sequence tags?
2012
Biological roles of glycans
2016 Standout
Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia
2013 Nature
Protein and Glycan Mimicry in HIV Vaccine Design
2019
HIV–host interactome revealed directly from infected cells
2016
The Epigenetics of Alzheimer’s Disease: Factors and Therapeutic Implications
2018
Alzheimer's disease
2016 Standout
Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
2013 StandoutNobel
Challenges for structure-based HIV vaccine design
2009
A Blueprint for HIV Vaccine Discovery
2012
Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization
2017 StandoutNobel
<p>Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics</p>
2019 Standout
De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease
2013
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure
2018
Structural insights into the specific anti-HIV property of actinohivin: structure of its complex with the α(1–2)mannobiose moiety of gp120
2012 StandoutNobel
Polymorphisms in microRNA target sites influence susceptibility to schizophrenia by altering the binding of miRNAs to their targets
2013
Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant
2011 StandoutNobel
Alzheimer's disease and epigenetic diet
2014
The epigenetics of aging and neurodegeneration
2015
Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy
2020 Standout
Jasmonates: biosynthesis, perception, signal transduction and action in plant stress response, growth and development. An update to the 2007 review in Annals of Botany
2013 Standout
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4
2015 StandoutNobel
Promiscuous Glycan Site Recognition by Antibodies to the High-Mannose Patch of gp120 Broadens Neutralization of HIV
2014
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
Broadly neutralizing antibodies abrogate established hepatitis C virus infection
2014 StandoutNobel
Kinetic mechanism for HIV-1 neutralization by antibody 2G12 entails reversible glycan binding that slows cell entry
2012
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
The Tomato odorless-2 Mutant Is Defective in Trichome-Based Production of Diverse Specialized Metabolites and Broad-Spectrum Resistance to Insect Herbivores
2010
Ginseng Protein Reverses Amyloid Beta Peptide and H2O2Cytotoxicity in Neurons, and Ameliorates Cognitive Impairment in AD Rats Induced by a Combination of D-Galactose and AlCl3
2016
Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development
2023 StandoutNobel
Structural insights into key sites of vulnerability on HIV ‐1 Env and influenza HA
2012
Quality and quantity of T FH cells are critical for broad antibody development in SHIV AD8 infection
2015
Glycan Microarrays as Chemical Tools for Identifying Glycan Recognition by Immune Proteins
2019
Actinohivin, a Broadly Neutralizing Prokaryotic Lectin, Inhibits HIV-1 Infection by Specifically Targeting High-Mannose-Type Glycans on the gp120 Envelope
2010
Works of Yu Geng being referenced
Rapid development of glycan-specific, broad, and potent anti–HIV-1 gp120 neutralizing antibodies in an R5 SIV/HIV chimeric virus infected macaque
2011
The miR-124 regulates the expression of BACE1/β-secretase correlated with cell death in Alzheimer's disease
2011
Antibodies against Man 1,2-Man 1,2-Man oligosaccharide structures recognize envelope glycoproteins from HIV-1 and SIV strains
2009
Antibodies elicited by yeast glycoproteins recognize HIV-1 virions and potently neutralize virions with high mannose N-glycans
2015
A Yeast Glycoprotein Shows High-Affinity Binding to the Broadly Neutralizing Human Immunodeficiency Virus Antibody 2G12 and Inhibits gp120 Interactions with 2G12 and DC-SIGN
2009
Multiple Biochemical and Morphological Factors Underlie the Production of Methylketones in Tomato Trichomes
2009
Enzymatic Functions of Wild Tomato Methylketone Synthases 1 and 2
2010
Yeast-Elicited Cross-Reactive Antibodies to HIV Env Glycans Efficiently Neutralize Virions Expressing Exclusively High-Mannose N-Linked Glycans
2010
An Engineered Saccharomyces cerevisiae Strain Binds the Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody 2G12 and Elicits Mannose-Specific gp120-Binding Antibodies
2008